Bisphosphonates, raloxifene and teriparatide for treating osteoporosis

24th August 2018 by Louise Hudman

Bisphosphonates, raloxifene and teriparatide for treating osteoporosis

This summary is based on 3 recent NICE guidelines:

Previous guidance was rather complicated in that different bisphosphonates could be used at different levels of risk. This has all been simplified as the cost of the drugs has reduced. Advice on using raloxifene and teriparatide hasn’t changed. Strontium and etidronate are no longer marketed in the UK.

There is quite a nice decision aid that can be used with patients on what the risk reduction is with different treatments.

Who is eligible for bisphosphonate treatment?

Read more

No credit card details needed – it takes two minutes.

Join free trial

Login

Already a member? Login to view this content.

Login

"Thank you so much for all your help over the past few years, and for running such a great resource for GP locums. "

Dr Sheelagh Donnelly, GP locum, Cumbria

See the full list of features within our NASGP membership plans

Membership